Stock Fundamentals

Company Information

Company Name
Brainsway Ltd
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US10501L1061
CIK: 0001076643
CUSIP: 10501L106
Currency: USD
Full Time Employees: 129
Phone: 972 2 582 4030
Fiscal Year End: December
IPO Date: Oct 06, 1999
Description:

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Address:

16 Hartum St, Jerusalem, Israel, 9777516

Directors & Officers

Name Title Year Born
Mr. Hadar Levy Chief Executive Officer 1974
Dr. David Zacut M.D. Co-Founder & Vice-Chairman 1953
Prof. Abraham Zangen Ph.D. Co-Founder, Member of Scientific Advisory Board & Director 1970
Mr. Ido Marom Chief Financial Officer 1976
Dr. Colleen Hanlon Ph.D. Vice President of Medical Affairs 1980
Mr. Michael Cohen Vice President of US Sales NA
Dr. Yiftach Roth Ph.D. Founder & Chief Scientific Officer 1971
Mr. Dor Hagai Vice President of Operations NA
Mr. Gilead Moiseyev Ph.D. Chief Technology Officer 1972
Mr. Menachem C. Klein Esq. VP, General Counsel & Corporate Secretary NA

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Valor Management LLC 5.31M Mar 31, 2026 13.26% $39.05 0.00%
Masters Capital Management LLC 1.65M Mar 31, 2026 4.12% $0.72 -17.50%
Acadian Asset Management LLC 818.27K Mar 31, 2026 2.04% $0.02 0.00%
Essex Investment Management Company, LLC 618.55K Mar 31, 2026 1.54% $1.30 1.68%
Renaissance Technologies Corp 518.42K Mar 31, 2026 1.29% $0.01 -6.38%
Cresset Asset Management, LLC 314.92K Mar 31, 2026 0.79% $0.02 0.00%
Y.D. More Investments Ltd 272.00K Mar 31, 2026 0.68% $0.14 18.30%
SEI Investments Co 226.38K Mar 31, 2026 0.56% $0.00 81.24%
ARK Investment Management LLC 193.69K Mar 31, 2026 0.48% $0.02 -23.94%
Legato Capital Management LLC 192.15K Mar 31, 2026 0.48% $0.23 -1.34%
Eagle Global Advisors, LLC 172.61K Mar 31, 2026 0.43% $0.08 6.15%
Two Sigma Investments LLC 128.19K Mar 31, 2026 0.32% $0.00 -15.32%
The Goldman Sachs Group Inc 107.71K Mar 31, 2026 0.27% $0.00 109.25%
Morgan Stanley - Brokerage Accounts 104.39K Mar 31, 2026 0.26% $0.00 13.08%
Royce & Associates, LP 97.03K Mar 31, 2026 0.24% $0.01 0.00%
Citadel Advisors Llc 87.05K Mar 31, 2026 0.22% $0.00 67.89%
UBS Group AG 82.14K Mar 31, 2026 0.20% $0.00 21.44%
Huntleigh Advisors Inc 81.52K Mar 31, 2026 0.20% $0.19 -53.19%
Trexquant Investment LP 77.15K Mar 31, 2026 0.19% $0.01 199.30%
Two Sigma Advisers, LLC 76.80K Dec 31, 2025 0.38% $0.00 -15.51%

Shares Statistics

Shares Outstanding: 40.09M
Shares Float: 26.59M
% Insiders: 603.10%
% Institutions: 2,984.10%
Short % Float: 0.44%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Timothy Plan Israel Common Values A 172.61K 0.44% ▲ 6.15% Mar 31, 2026
2 ARK Israel Innovative Technology ETF 142.50K 0.36% ▲ 0.00% May 31, 2026
3 1290 Essex Small Cap Growth I 138.59K 0.35% ▲ 1.45% Apr 30, 2026
4 Pleiades Small Cap Equity A 97.35K 0.25% ▲ 4.42% Mar 31, 2026
5 Royce Smaller-Companies Growth Svc 97.00K 0.25% ▲ 0.00% Mar 31, 2026
6 Steward Values Enhanced International I 25.35K 0.06% ▼ 15.39% Apr 30, 2026
7 ActivePassive International Equity ETF 19.01K 0.05% ▲ 0.00% May 29, 2026
8 Mandarine Global Microcap G EUR 16.50K 0.04% ▼ 8.33% Mar 31, 2026
9 Even Herd Long Short ETF 15.06K 0.04% ▲ 0.00% May 29, 2026
10 Fidelity Nasdaq Composite Index 13.71K 0.04% ▲ 0.00% Apr 30, 2026

Valuation Metrics

Enterprise Value: $529.95M
Trailing P/E: 66.50
Forward P/E: 34.84

Financial Highlights

Market Cap: $586.56M
EBITDA: $6.62M
P/E Ratio: $66.50
Book Value: $1.99
Earnings/Share: $0.22
Profit Margin: 15.58%
Operating Margin: 12.91%
ROA (TTM): 3.31%
ROE (TTM): 12.55%
Revenue (TTM): $56.22M
Revenue/Share (TTM): $1.47
Earnings Growth (YOY): 200.00%
Revenue Growth (YOY): 34.60%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 3.83x 0.01x 0.35x 1.94x 0.09x
2024-12-31 5.19x 0.01x 0.34x 1.03x 0.15x
2023-12-31 5.68x 0.01x 0.34x -16.64x -0.09x
2022-12-31 7.14x 0.01x 0.30x -186.51x -0.02x
2021-12-31 7.22x 0.01x 0.24x -35.45x -0.11x
2020-12-31 3.57x 0.02x 0.42x -15.14x -0.20x
2019-12-31 4.29x 0.02x 0.37x -16.75x -0.06x
2018-12-31 1.62x 0.41x 0.71x -12.95x -0.64x
2017-12-31 2.92x 0.34x 0.53x -49.34x -0.78x
2016-12-31 2.98x 0.08x 0.48x -33.92x -0.60x
2015-12-31 3.04x 0.01x 0.42x -121.76x -0.04x
2014-12-31 3.62x 0.01x 0.40x -13.86x -0.03x
2013-12-31 4.06x 0.00x 0.18x -15.08x -0.01x
2012-12-31 5.91x 0.00x 0.26x N/A 0.00x
2000-12-31 0.00x 0.10x 0.45x N/A N/A

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about BWAY.US!